Please login to the form below
Decibel Therapeutics
This page shows the latest Decibel Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Biotech leaders jump into US free speech debate
Alnylam chief executive John Maraganore, Decibel Therapeutics’ CEO Steve Holtzman, Acorda CEO Ron Cohen and Jeremy Levin of Ovid Therapeutics are the main signatories to the letter published In Nature, but
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Decibel Therapeutics expands leadership team
Hearing disorders specialist Decibel Therapeutics has expanded its leadership team and board of directors with four new appointments. ... products. . Steve Holtzman, president and chief executive of Decibel Therapeutics, said: “We are thrilled to
-
Decibel Therapeutics appoints former Biogen exec as president and CEO
Steven Holtzman succeeds interim CEO Kevin Starr. Decibel Therapeutics has appointed Steven Holtzman as its new president and chief executive officer, succeeding interim chief executive Kevin Starr.
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Midweight Brand Planner
-
Up to £50, 000
- NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Medical Writer
-
Salary TBC
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
Subscribe to our email news alerts
- Grail’s multi-cancer blood test gets FDA breakthrough status
- Moving annual total (MAT)
- Communique - Communiqué Awards
- Babylon expansion sparks ‘NHS destruction’ warnings
- Spinraza managed access deal in England breaks deadlock for Biogen
- Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019
- There is no such thing as good medical communications
- Genentech forges $800m autoimmune alliance with Parvus
- So far so good for Amgen's much-anticipated KRAS inhibitor
- It’s OK to not be OK: Bedrock breaks down mental health stigma
- After discount row, NICE finally says yes to first line Revlimid
- Transitions in healthcare
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- Investing in our People
- As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....
- Body image and mental health: The psoriasis connection
- As part of mental health awareness week, the Mental Health Foundation (MHF) have released a new report on the interaction between body image and mental health. Our Medical Writer Alex...
- It’s not the end of the world, is it?
- Industry change isn’t always gradual – it can be apocalyptic...
Quick links
Infographics
